Movement disorders encompass a group of neurological conditions that affect the control, speed, and smoothness of voluntary and involuntary movements. These include Parkinson’s disease, dystonia, essential tremor, chorea, ataxia, and Tourette syndrome, among others. Each condition reflects dysfunction in the basal ganglia, cerebellum, or motor pathways responsible for coordination and muscle tone.

The Movement Disorders session explores the mechanisms, diagnosis, and treatment of motor dysfunctions from both clinical and research perspectives. Scientists investigate the neurobiological underpinnings of abnormal movement, focusing on neurotransmitter imbalances, neurodegeneration, and disrupted circuitry within the motor system.

At the Movement Disorders Conference, neurologists, neuroscientists, and physiotherapists share findings on genetics, neuroimaging, pharmacology, and rehabilitation. Key themes include the role of dopamine in motor control, neuromodulation through deep brain stimulation (DBS), and gene therapy advancements targeting hereditary syndromes.

This session provides a multidisciplinary platform for clinicians and researchers aiming to enhance early diagnosis, develop novel therapies, and improve patient quality of life. It also emphasizes how behavioral interventions, physical therapy, and adaptive technologies support long-term management.

Cutting-edge insights from Neurophysiology Research are redefining motor-network understanding—revealing how disrupted signaling leads to motor impairment and how targeted therapies can restore movement precision.